Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 53

1.

Opioid Prescribing Rates in Nonmetropolitan and Metropolitan Counties Among Primary Care Providers Using an Electronic Health Record System - United States, 2014-2017.

García MC, Heilig CM, Lee SH, Faul M, Guy G, Iademarco MF, Hempstead K, Raymond D, Gray J.

MMWR Morb Mortal Wkly Rep. 2019 Jan 18;68(2):25-30. doi: 10.15585/mmwr.mm6802a1.

2.

Modernizing Centers for Disease Control and Prevention Informatics Using Surveillance Data Platform Shared Services.

Lee B, Martin T, Khan A, Fullerton K, Duck W, Kinley T, Stoutenburg S, Hall J, Crum M, Garcia MC, Iademarco MF, Richards CL.

Public Health Rep. 2018 Mar/Apr;133(2):130-135. doi: 10.1177/0033354917751130. Epub 2018 Feb 8. No abstract available.

3.

The Public Health Community Platform, Electronic Case Reporting, and the Digital Bridge.

Cooney MA, Iademarco MF, Huang M, MacKenzie WR, Davidson AJ.

J Public Health Manag Pract. 2018 Mar/Apr;24(2):185-189. doi: 10.1097/PHH.0000000000000775.

PMID:
29360697
4.

Advances in Public Health Surveillance and Information Dissemination at the Centers for Disease Control and Prevention.

Richards CL, Iademarco MF, Atkinson D, Pinner RW, Yoon P, Mac Kenzie WR, Lee B, Qualters JR, Frieden TR.

Public Health Rep. 2017 Jul/Aug;132(4):403-410. doi: 10.1177/0033354917709542. Epub 2017 Jun 13. No abstract available.

5.

The Promise of Electronic Case Reporting.

Mac Kenzie WR, Davidson AJ, Wiesenthal A, Engel JP, Turner K, Conn L, Becker SJ, Moffatt S, Groseclose SL, Jellison J, Stinn J, Garrett NY, Helmus L, Harmon B, Richards CL, Lumpkin JR, Iademarco MF.

Public Health Rep. 2016 Nov;131(6):742-746. doi: 10.1177/0033354916670871. Epub 2016 Oct 13. Review. No abstract available.

6.

Leading Causes of Death in Nonmetropolitan and Metropolitan Areas- United States, 1999-2014.

Moy E, Garcia MC, Bastian B, Rossen LM, Ingram DD, Faul M, Massetti GM, Thomas CC, Hong Y, Yoon PW, Iademarco MF.

MMWR Surveill Summ. 2017 Jan 13;66(1):1-8. doi: 10.15585/mmwr.ss6601a1. Erratum in: MMWR Morb Mortal Wkly Rep. 2017 Jan 27;66(3):93.

7.

Reducing Potentially Excess Deaths from the Five Leading Causes of Death in the Rural United States

Garcia MC, Faul M, Massetti G, Thomas CC, Hong Y, Bauer UE, Iademarco MF.

MMWR Surveill Summ. 2017 Jan 13;66(2):1-7. doi: 10.15585/mmwr.ss6602a1. Erratum in: MMWR Morb Mortal Wkly Rep. 2017 Jan 27;66(3):93.

8.

Potentially Preventable Deaths Among the Five Leading Causes of Death - United States, 2010 and 2014.

García MC, Bastian B, Rossen LM, Anderson R, Miniño A, Yoon PW, Faul M, Massetti G, Thomas CC, Hong Y, Iademarco MF.

MMWR Morb Mortal Wkly Rep. 2016 Nov 18;65(45):1245-1255. doi: 10.15585/mmwr.mm6545a1.

9.

Declines in Opioid Prescribing After a Private Insurer Policy Change - Massachusetts, 2011-2015.

García MC, Dodek AB, Kowalski T, Fallon J, Lee SH, Iademarco MF, Auerbach J, Bohm MK.

MMWR Morb Mortal Wkly Rep. 2016 Oct 21;65(41):1125-1131. doi: 10.15585/mmwr.mm6541a1.

10.

Assessing Clinical Research Capacity in Vietnam: A Framework for Strengthening Capability for Clinical Trials in Developing Countries.

Kagan J, Giang DD, Iademarco MF, Phung VT, Lau CY, Quang NN.

Public Health Rep. 2016 May-Jun;131(3):396-403.

11.

A Conceptual Framework for Allocation of Federally Stockpiled Ventilators During Large-Scale Public Health Emergencies.

Zaza S, Koonin LM, Ajao A, Nystrom SV, Branson R, Patel A, Bray B, Iademarco MF.

Health Secur. 2016 Jan-Feb;14(1):1-6. doi: 10.1089/hs.2015.0043. Epub 2016 Feb 1.

PMID:
26828799
12.

Precision Public Health for the Era of Precision Medicine.

Khoury MJ, Iademarco MF, Riley WT.

Am J Prev Med. 2016 Mar;50(3):398-401. doi: 10.1016/j.amepre.2015.08.031. Epub 2015 Nov 4. Review. No abstract available.

13.

A new strategy for public health surveillance at CDC: improving national surveillance activities and outcomes.

Richards CL, Iademarco MF, Anderson TC.

Public Health Rep. 2014 Nov-Dec;129(6):472-6. No abstract available.

14.

Strengthening global health security capacity--Vietnam demonstration project, 2013.

Tran PD, Vu LN, Nguyen HT, Phan LT, Lowe W, McConnell MS, Iademarco MF, Partridge JM, Kile JC, Do T, Nadol PJ, Bui H, Vu D, Bond K, Nelson DB, Anderson L, Hunt KV, Smith N, Giannone P, Klena J, Beauvais D, Becknell K, Tappero JW, Dowell SF, Rzeszotarski P, Chu M, Kinkade C; Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2014 Jan 31;63(4):77-80.

15.

Rapidly building global health security capacity--Uganda demonstration project, 2013.

Borchert JN, Tappero JW, Downing R, Shoemaker T, Behumbiize P, Aceng J, Makumbi I, Dahlke M, Jarrar B, Lozano B, Kasozi S, Austin M, Phillippe D, Watson ID, Evans TJ, Stotish T, Dowell SF, Iademarco MF, Ransom R, Balajee A, Becknell K, Beauvais D, Wuhib T; Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2014 Jan 31;63(4):73-6.

16.

2011: the year in review. Part II: tuberculosis and lung disease.

Iademarco MF, Koh WJ.

Int J Tuberc Lung Dis. 2012 Oct;16(10):1291-9. doi: 10.5588/ijtld.12.0566. Review. No abstract available.

PMID:
23107631
17.

Challenges and controversies in defining totally drug-resistant tuberculosis.

Cegielski P, Nunn P, Kurbatova EV, Weyer K, Dalton TL, Wares DF, Iademarco MF, Castro KG, Raviglione M.

Emerg Infect Dis. 2012 Nov;18(11):e2. doi: 10.3201/eid1811.120526.

18.

Chest radiography for tuberculosis screening is back on the agenda.

Iademarco MF, O'Grady J, Lönnroth K.

Int J Tuberc Lung Dis. 2012 Nov;16(11):1421-2. doi: 10.5588/ijtld.12.0774. No abstract available.

PMID:
23044441
19.

Clinical research and development of tuberculosis diagnostics: moving from silos to synergy.

Nahid P, Kim PS, Evans CA, Alland D, Barer M, Diefenbach J, Ellner J, Hafner R, Hamilton CD, Iademarco MF, Ireton G, Kimerling ME, Lienhardt C, MacKenzie WR, Murray M, Perkins MD, Posey JE, Roberts T, Sizemore C, Stevens WS, Via L, Williams SD, Yew WW, Swindells S.

J Infect Dis. 2012 May 15;205 Suppl 2:S159-68. doi: 10.1093/infdis/jis194. Epub 2012 Apr 3. Review.

20.

Performance of tuberculosis drug susceptibility testing in U.S. laboratories from 1994 to 2008.

Angra PK, Taylor TH, Iademarco MF, Metchock B, Astles JR, Ridderhof JC.

J Clin Microbiol. 2012 Apr;50(4):1233-9. doi: 10.1128/JCM.06479-11. Epub 2012 Feb 1.

21.

Nontuberculous mycobacteria infections and anti-tumor necrosis factor-alpha therapy.

Winthrop KL, Chang E, Yamashita S, Iademarco MF, LoBue PA.

Emerg Infect Dis. 2009 Oct;15(10):1556-61. doi: 10.3201/eid1510.090310. Review.

22.

Increasing proportions of advanced pulmonary tuberculosis reported in the United States: are delays in diagnosis on the rise?

Wallace RM, Kammerer JS, Iademarco MF, Althomsons SP, Winston CA, Navin TR.

Am J Respir Crit Care Med. 2009 Nov 15;180(10):1016-22. doi: 10.1164/rccm.200901-0059OC. Epub 2009 Aug 13.

PMID:
19679694
23.

Validation of the line-probe assay for rapid detection of rifampicin-resistant Mycobacterium tuberculosis in Vietnam.

Shah NS, Lan NT, Huyen MN, Laserson K, Iademarco MF, Binkin N, Wells C, Varma JK.

Int J Tuberc Lung Dis. 2009 Feb;13(2):247-52.

PMID:
19146755
24.

Comparison of tuberculosis surveillance systems in low-incidence industrialised countries.

Mor Z, Migliori GB, Althomsons SP, Loddenkemper R, Trnka L, Iademarco MF.

Eur Respir J. 2008 Dec;32(6):1616-24. doi: 10.1183/09031936.00042908. Epub 2008 Aug 6.

25.

Trends in tuberculosis reported from the Appalachian region: United States, 1993-2005.

Wallace RM, Armstrong LR, Pratt RH, Kammerer JS, Iademarco MF.

J Rural Health. 2008 Summer;24(3):236-43. doi: 10.1111/j.1748-0361.2008.00164.x.

PMID:
18643800
26.

An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases.

Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F, Holland SM, Horsburgh R, Huitt G, Iademarco MF, Iseman M, Olivier K, Ruoss S, von Reyn CF, Wallace RJ Jr, Winthrop K; ATS Mycobacterial Diseases Subcommittee; American Thoracic Society; Infectious Disease Society of America.

Am J Respir Crit Care Med. 2007 Feb 15;175(4):367-416. Review. No abstract available. Erratum in: Am J Respir Crit Care Med. 2007 Apr 1;175(7):744-5. Dosage error in article text.

PMID:
17277290
27.

Tuberculosis among foreign-born persons in the United States: achieving tuberculosis elimination.

Cain KP, Haley CA, Armstrong LR, Garman KN, Wells CD, Iademarco MF, Castro KG, Laserson KF.

Am J Respir Crit Care Med. 2007 Jan 1;175(1):75-9. Epub 2006 Oct 12.

PMID:
17038659
28.

Severe or fatal liver injury in 50 patients in the United States taking rifampin and pyrazinamide for latent tuberculosis infection.

Ijaz K, Jereb JA, Lambert LA, Bower WA, Spradling PR, McElroy PD, Iademarco MF, Navin TR, Castro KG.

Clin Infect Dis. 2006 Feb 1;42(3):346-55. Epub 2005 Dec 28.

PMID:
16392079
29.

Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care settings, 2005.

Jensen PA, Lambert LA, Iademarco MF, Ridzon R; CDC.

MMWR Recomm Rep. 2005 Dec 30;54(RR-17):1-141.

30.

Guidelines for using the QuantiFERON-TB Gold test for detecting Mycobacterium tuberculosis infection, United States.

Mazurek GH, Jereb J, Lobue P, Iademarco MF, Metchock B, Vernon A; Division of Tuberculosis Elimination, National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention (CDC).

MMWR Recomm Rep. 2005 Dec 16;54(RR-15):49-55. Erratum in: MMWR Morb Mortal Wkly Rep. 2005 Dec 23;54(50):1288.

31.

Tuberculosis associated with therapy against tumor necrosis factor alpha.

Winthrop KL, Siegel JN, Jereb J, Taylor Z, Iademarco MF.

Arthritis Rheum. 2005 Oct;52(10):2968-74. Review. No abstract available.

32.

National survey to measure rates of liver injury, hospitalization, and death associated with rifampin and pyrazinamide for latent tuberculosis infection.

McElroy PD, Ijaz K, Lambert LA, Jereb JA, Iademarco MF, Castro KG, Navin TR.

Clin Infect Dis. 2005 Oct 15;41(8):1125-33. Epub 2005 Sep 9. Erratum in: Clin Infect Dis. 2006 Jan 15;42(2):313.

PMID:
16163632
34.

Capacity building for international tuberculosis control through operations research training.

Laserson KF, Binkin NJ, Thorpe LE, Laing R, Iademarco MF, Bloom A, Agerton TB, Nelson L, Cegielski JP, Ferroussier O, Holtz T, Vitek E, Gammino V, Tan K, Finlay A, Dewan P, Miranda A, Aquino G, Weyer K, Sy DN, Vernon A, Becerra J, Ershova J, Wells CD.

Int J Tuberc Lung Dis. 2005 Feb;9(2):145-50.

PMID:
15732732
35.

Tuberculosis transmission in nontraditional settings: a decision-tree approach.

Kammerer JS, McNabb SJ, Becerra JE, Rosenblum L, Shang N, Iademarco MF, Navin TR.

Am J Prev Med. 2005 Feb;28(2):201-7.

PMID:
15710276
36.

In the treatment of tuberculosis, you get what you pay for...

Vernon AA, Iademarco MF.

Am J Respir Crit Care Med. 2004 Nov 15;170(10):1040-2. No abstract available.

PMID:
15533952
37.

Evaluation and epidemiological research in tuberculosis control: linking medical care and public health.

Iademarco MF, Sodt D, Sutherland WM.

Mayo Clin Proc. 2004 Sep;79(9):1110-2. No abstract available.

PMID:
15357031
38.

Tuberculosis serodiagnosis in a predominantly HIV-infected population of hospitalized patients with cough, Botswana, 2002.

Talbot EA, Hay Burgess DC, Hone NM, Iademarco MF, Mwasekaga MJ, Moffat HJ, Moeti TL, Mwansa RA, Letsatsi P, Gokhale NT, Kenyon TA, Wells CD.

Clin Infect Dis. 2004 Jul 1;39(1):e1-7. Epub 2004 Jun 14.

PMID:
15206074
39.

Epidemiology of tuberculosis.

Iademarco MF, Castro KG.

Semin Respir Infect. 2003 Dec;18(4):225-40. Review.

PMID:
14679472
40.

Detection of Mycobacterium tuberculosis infection by whole-blood interferon-gamma release assay.

Mazurek GH, LoBue PA, Daley CL, Bernardo J, Lardizabal AA, Iademarco MF.

Clin Infect Dis. 2003 May 1;36(9):1207-8; author reply 1209-10. No abstract available.

PMID:
12715323
41.

Management of latent tuberculosis infection in immigrants.

Marks SM, Ijaz K, Iademarco MF.

N Engl J Med. 2003 Mar 27;348(13):1289-92; author reply 1289-92. No abstract available.

42.

Childhood vaccinations and risk of asthma.

DeStefano F, Gu D, Kramarz P, Truman BI, Iademarco MF, Mullooly JP, Jackson LA, Davis RL, Black SB, Shinefield HR, Marcy SM, Ward JI, Chen RT; Vaccine Safety Datalink Research Group.

Pediatr Infect Dis J. 2002 Jun;21(6):498-504.

PMID:
12182372
43.

Comparison of a whole-blood interferon gamma assay with tuberculin skin testing for detecting latent Mycobacterium tuberculosis infection.

Mazurek GH, LoBue PA, Daley CL, Bernardo J, Lardizabal AA, Bishai WR, Iademarco MF, Rothel JS.

JAMA. 2001 Oct 10;286(14):1740-7.

PMID:
11594899
44.

Profiling drug resistance in immigrants with tuberculosis.

Laserson KF, Iademarco MF.

Chest. 2000 Mar;117(3):623-5. No abstract available.

PMID:
10712981
45.

Assessing excess deaths in St. Louis, Missouri: 1980 to 1994.

Iademarco MF, Biek RW, Fields L, Brownson RC.

J Public Health Manag Pract. 1999 Nov;5(6):41-54.

PMID:
10662063
46.
47.
48.

Control of vascular cell adhesion molecule-1 gene promoter activity during neural differentiation.

Sheppard AM, McQuillan JJ, Iademarco MF, Dean DC.

J Biol Chem. 1995 Feb 24;270(8):3710-9.

49.
50.

Supplemental Content

Loading ...
Support Center